Donepezil for dementia due to Alzheimer's disease

Author:

Birks Jacqueline S1,Harvey Richard J2

Affiliation:

1. University of Oxford; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences; Botnar Research Centre, Windmill Road Oxford UK OX3 7LD

2. Deakin University and Private Practice; Medical School; c/o Telepsychiatrist Online PO Box 117 North Geelong Victoria Australia 3215

Publisher

Wiley

Subject

Pharmacology (medical)

Reference301 articles.

1. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial;AD2000 Collaborative Group;Lancet,2004

2. Bentham P Gray R Hill R Sellwood E Courtney C Twelve week response to cholinesterase inhibitors dose not predict future benefit the AD2000 trial experience The 8th conference on Alzheimer's disease and related disorders, July 20-25, 2002, Stockholm, Sweden 2002 337

3. Lendon CL Determination of responses to anticholinesterase therapy in the treatment of Alzheimer's disease 8th International Conference on Alzheimer's Disease and Related Disorders; 2002 July 20-25, Stockholm, Sweden: Abstract No 1287 2002

4. Roberts N A reliable assessment of the efficacy and safety of donepezil and aspirin in Alzheimer's disease (AD2000) National Research Register 2001

5. AD2000: donepezil in Alzheimer's disease;Schneider;Lancet,2004

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3